Business Context and Reporting Period
This Form 8-K was filed by ENDRA Life Sciences Inc. on March 19, 2026, reporting events occurring on that date and a subsequent announcement on March 25, 2026. The Company, incorporated in Delaware and trading on Nasdaq under the symbol NDRA, is headquartered in Ann Arbor, Michigan.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or liquidity metrics. The only specific financial data disclosed relates to a one-time charge:
- Severance Charges: The Company expects to incur pre-tax cash charges of approximately $51,000 associated with employee severance payments.
- Recognition Period: These charges are expected to be recognized in the first quarter of 2026.
Material Changes
The filing reports a significant shift in corporate strategy and operational structure:
- Workforce Reduction: On March 19, 2026, the Company reduced its employee count to lower cash expenditures and extend its operational runway.
- Strategic Review: On March 25, 2026, the Company announced the initiation of a process to evaluate a range of strategic alternatives aimed at maximizing shareholder value.
- Business Continuity: Despite the strategic review, the Company stated it will continue to pursue its TAEUS business.
Outlook, Risks, and Management Commentary
Management commentary indicates that the workforce reduction and strategic review are direct responses to the need to preserve cash and extend the operational runway. The $51,000 severance charge is explicitly linked to this change in strategic direction. The filing includes a press release (Exhibit 99.1) detailing the strategic alternatives process, though the specific nature of these alternatives (e.g., merger, acquisition, liquidation) is not detailed in the text provided.
Investor Verification Checklist
- Verify the specific terms and timeline of the "strategic alternatives" process announced on March 25, 2026.
- Confirm the exact number of employees reduced and the impact on the Company's remaining operational capacity.
- Review the Company's current cash balance and burn rate to assess the sufficiency of the extended operational runway.
- Monitor subsequent filings for updates on the strategic review process and any potential transactions.